Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Bone Marrow Transplantation, Published online: 30 May 2023; doi:10.1038/s41409-023-02012-5Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Source: Bone Marrow Transplantation - May 30, 2023 Category: Hematology Authors: Arnon Nagler Myriam Labopin Ryszard Swoboda Alexander Kulagin Andrea Velardi Jaime Sanz H élène Labussière-Wallet Victoria Potter J ürgen Kuball Simona Sica Elena Parovichnikova Wolfgang Bethge Natacha Maillard Uwe Platzbecker Friedrich St ölzel Fabi Source Type: research